06185.HK
CanSino Biologics Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 29.22
−0.61%Forward multiples
Based on analyst estimates
- P/E forward
- 45.93x
- P/E 2026E
- 64.21x
- P/E 2027E
- 21.47x
- P/E 2028E
- 10.13x
- P/S forward
- 6.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- 155.75x
- PEG TTM
- 0.65x
- Price / book
- 1.24x
- Price / sales
- 5.04x
- Price / cash flow
- 153.73x
Enterprise value
- Enterprise value
- HKD 6.2B
- EV / sales
- 4.34x
- EV / EBITDA
- 139.46x
- EV / EBIT
- -93.87x
- Market cap
- HKD 7.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026